| 47.06 Real-Time Quote |  +3.00 / +6.81%Today’s Change | 30.64 Today|||52-Week Range 46.92 | +44.40% Year-to-Date |
| Bristol-Myers Squibb Reaches New 52-Week High (BMY) 11:32am / TheStreet.com | Analysts' Actions: AMAT ARUN BMY DE WSM May 17 / TheStreet.com |
| Cramer's Top Stock Picks: SAVE GILD BMY HTA TSLA May 21 / TheStreet.com | 5 Stock Trades for S&P 1,700 May 16 / TheStreet.com |
| Cramer's 'Mad Money' Recap: Think Dividends, Not Coupons May 20 / TheStreet.com | ASCO '13 Preview: New 'Anti-PD-1' Therapies Shrink Tumors May 15 / TheStreet.com |
| 5 Drugs Stocks On The Rise May 20 / TheStreet.com | Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog May 15 / Zacks.com |
| Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner May 17 / TheStreet.com | India: Patents and precedents May 15 / FT.com |
| Previous close | 44.06 |
| Today’s open | 44.84 |
| Day’s range | 44.84 - 46.92 |
| Volume | 11,037,068 |
| Average volume (3 months) | 10,022,907 |
| Market cap | $72.4B |
| Dividend yield | 2.99% |
| Earnings growth (last year) | -46.30% |
| Earnings growth (this year) | -8.61% |
| Earnings growth (next 5 years) | +9.50% |
| Revenue growth (last year) | -17.05% |
| P/E ratio | 53.9 |
| Price/Sales | 3.09 |
| Price/Book | 5.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie Inc | +1.19 | +2.56% |
| NVONovo Nordisk A/S | +0.42 | +0.25% |
| AZNAstraZeneca PLC | +0.97 | +1.88% |
| LLYEli Lilly and Co | +0.48 | +0.87% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $17.6B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 11.12% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Director Lamberto Andreotti |
Chief Financial Officer & Executive Vice President Charles A. Bancroft, MBA, CPA |
Corporate headquarters New York, New York |
.
